Motion: To amend existing policy: 2018 Proactive Immunization Assessment and Immunization Information Systems, Statement #3

3. APhA calls for a National Immunization Information Systems (IIS) database to report all immunization data among all state registries APhA supports nationwide integration of Immunization Information Systems (IIS) that incorporates federal, state, and local databases for the purpose of providing pharmacists and other health care professionals with accurate and timely information to assist in clinical decision making related to immunization services.3

 Motion:

1. APhA supports the expansion of patient access to diabetes self-management education and support.
2. APhA calls upon public and private payers to recognize and reimburse pharmacists as providers of diabetes self-management education and support regardless of practice setting. 
3. APhA supports the development of a guide for pharmacists seeking appropriate reimbursement from payors for diabetes self-management education and support.

Motion:

1. APhA urges pharmacists to use evidence-based data to address health disparities, equitably distribute resources, and drive decision-making in advocacy and practice.
2. APhA supports the collection, analysis, reporting, and exchange of disaggregated data regarding race, ethnicity, language, sexual orientation, gender identity, and social determinants of health in partnership with the impacted communities.
3. APhA urges schools and colleges of pharmacy to prioritize and incentivize the collection and analysis of disaggregated data as part of institutional research efforts towards health equity.

Motion:

1. APhA supports medication procurement strategies that meet chain of custody standards for pharmaceutical products moving from one entity to another; ensuring the exchanges are accurate, timely, and follow best practices prior to administering the product to the patient; and preserve the economic viability of pharmacy practices.
2. APhA opposes required procurement strategies (e.g., site of care steerage, brown bagging, and white bagging) that restrict the patient’s and providers’ ability to choose treatment options that may lead to or result in fragmented care between the patient, pharmacist and other healthcare providers.
3. APhA calls for the creation of operational efficiencies that allow the patient’s choice of pharmacy and site of care; do not restrict or delay care; and ensure continuity of care through collaborative efforts between providers that leads to optimal patient health outcomes.

Motion: To adopt the following policy statement listed below: APhA supports expanding access to medication-assisted treatments (MAT) by permitting pharmacists’ prescriptive authority for the management of substance use disorders.